KEWAUNEE SCIENTIFIC CP (KEQU) Fundamental Analysis & Valuation

NASDAQ:KEQU • US4928541048

Current stock price

37.716 USD
+0.71 (+1.91%)
Last:

This KEQU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. KEQU Profitability Analysis

1.1 Basic Checks

  • In the past year KEQU was profitable.
  • KEQU had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
  • In multiple years KEQU reported negative operating cash flow during the last 5 years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.30%, KEQU belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 15.68%, KEQU belongs to the top of the industry, outperforming 89.84% of the companies in the same industry.
  • KEQU's Return On Invested Capital of 12.17% is amongst the best of the industry. KEQU outperforms 93.05% of its industry peers.
  • KEQU had an Average Return On Invested Capital over the past 3 years of 9.90%. This is in line with the industry average of 9.14%.
  • The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(12.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.3%
ROE 15.68%
ROIC 12.17%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • The Profit Margin of KEQU (3.85%) is better than 75.40% of its industry peers.
  • KEQU has a better Operating Margin (6.95%) than 73.80% of its industry peers.
  • KEQU has a Gross Margin of 28.93%. This is in the lower half of the industry: KEQU underperforms 75.40% of its industry peers.
  • KEQU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.95%
PM (TTM) 3.85%
GM 28.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. KEQU Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
  • The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for KEQU has been increased compared to 5 years ago.
  • The debt/assets ratio for KEQU is higher compared to a year ago.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • KEQU has an Altman-Z score of 3.51. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.51, KEQU is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
  • KEQU has a debt to FCF ratio of 2.61. This is a good value and a sign of high solvency as KEQU would need 2.61 years to pay back of all of its debts.
  • KEQU has a better Debt to FCF ratio (2.61) than 82.89% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that KEQU is somewhat dependend on debt financing.
  • The Debt to Equity ratio of KEQU (0.62) is worse than 65.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.61
Altman-Z 3.51
ROIC/WACC1.53
WACC7.94%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • KEQU has a Current Ratio of 2.12. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
  • KEQU has a worse Current ratio (2.12) than 60.43% of its industry peers.
  • A Quick Ratio of 1.45 indicates that KEQU should not have too much problems paying its short term obligations.
  • KEQU has a Quick ratio of 1.45. This is in the lower half of the industry: KEQU underperforms 64.17% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.45
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. KEQU Growth Analysis

3.1 Past

  • KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.07%.
  • KEQU shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.78%.
  • KEQU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.27% yearly.
EPS 1Y (TTM)-37.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.31%
Revenue 1Y (TTM)30.78%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%3.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. KEQU Valuation Analysis

4.1 Price/Earnings Ratio

  • KEQU is valuated reasonably with a Price/Earnings ratio of 8.90.
  • Based on the Price/Earnings ratio, KEQU is valued cheaper than 93.58% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.64. KEQU is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.9
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 97.33% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 98.93% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.68
EV/EBITDA 5.56
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KEQU Dividend Analysis

5.1 Amount

  • No dividends for KEQU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KEQU Fundamentals: All Metrics, Ratios and Statistics

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (5/1/2026, 8:00:03 PM)

37.716

+0.71 (+1.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.63
Earnings (Last)03-11
Earnings (Next)06-23
Inst Owners42.06%
Inst Owner Change1.23%
Ins Owners15.69%
Ins Owner Change-1.37%
Market Cap108.24M
Revenue(TTM)287.75M
Net Income(TTM)11.08M
Analysts82.86
Price TargetN/A
Short Float %1.95%
Short Ratio7.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.9
Fwd PE N/A
P/S 0.38
P/FCF 5.68
P/OCF 4.79
P/B 1.53
P/tB 2.61
EV/EBITDA 5.56
EPS(TTM)4.24
EY11.24%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.64
FCFY17.6%
OCF(TTM)7.87
OCFY20.86%
SpS100.26
BVpS24.63
TBVpS14.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number48.4692 (28.51%)
Profitability
Industry RankSector Rank
ROA 6.3%
ROE 15.68%
ROCE 15.73%
ROIC 12.17%
ROICexc 13%
ROICexgc 17.14%
OM 6.95%
PM (TTM) 3.85%
GM 28.93%
FCFM 6.62%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.61
Debt/EBITDA 1.67
Cap/Depr 55.94%
Cap/Sales 1.23%
Interest Coverage 4.36
Cash Conversion 85.86%
Profit Quality 171.98%
Current Ratio 2.12
Quick Ratio 1.45
Altman-Z 3.51
F-Score6
WACC7.94%
ROIC/WACC1.53
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.78%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%3.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.25%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y24.21%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 5 / 10 to KEQU.


What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


Can you provide the profitability details for KEWAUNEE SCIENTIFIC CP?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


What is the valuation of KEWAUNEE SCIENTIFIC CP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for KEWAUNEE SCIENTIFIC CP (KEQU) is 8.9 and the Price/Book (PB) ratio is 1.53.